Morgan Stanley’s $38 target on NRIX

NRIX Nurix Therapeutics Inc

$23.4 → $38 (+62%) by Jul 2027

Overweight · raises · said Jul 27, 2026 · 12-month default horizon

Open: judged on the close on Jul 27, 2027

The article this target came from

Morgan Stanley raises Nurix stock price target on growth potential

Investing.com · Jul 27, 2026

Morgan Stanley raised its price target on Nurix Therapeutics shares (NASDAQ:NRIX) to $38.00 from $36.00

Morgan Stanley’s track record → Nurix Therapeutics Inc →

A fact about what Morgan Stanley published, as reported by Investing.com, not a recommendation from Dalsna Finance; Morgan Stanley is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.